Elizabeth Holland, a senior partner in Goodwin's IP Litigation Group and member of its Executive Committee, is an experienced trial lawyer who focuses exclusively on patent infringement and related litigation. With almost 30 years of experience, Ms. Holland has served as lead trial counsel in numerous patent infringement litigations and IPR proceedings, and has argued several Federal Circuit appeals. She has particular expertise in Hatch-Waxman litigation on behalf of both branded and generic drug companies, and in biosimilars litigation.

Ms. Holland is consistently ranked among the top lawyers in her field by publications such as Chambers USA,  IAM 1000 – The World's Leading Patent Practitioners, The Legal 500 U.S., Managing Intellectual Property, LMG Life Sciences and Euromoney, which have noted her “assured handling of even the most complex pharmaceuticals patent cases” and have described her as a litigator who is “exceptional on her feet in court;” gets “excellent results;” and “understands clients’ business goals and litigates with those in mind.” Most recently, Ms. Holland was named “Hatch Waxman Litigator of the Year” by LMG Life Sciences and was featured as a “Winning Litigator” in the National Law Journal.





Professional Activities

Ms. Holland is a member of AIPLA, NYIPLA and the Federal Circuit Bar Association.

Professional Experience

Ms. Holland has successfully represented companies such as Teva, Actavis, Lupin, Sun, Ceva Sante, Enzymotec, Celltrion and Boston Scientific in patent litigation in district courts throughout the United States, at the International Trade Commission, in post-grant proceedings before the PTAB, and at the Federal Circuit. Ms. Holland has also coordinated worldwide patent litigation, and has particular experience with courts in the U.K., Netherlands, France, Israel, India and Mexico.

Ms. Holland’s significant victories include:

  • Wins in S.D.N.Y. (after trial), Federal Circuit and U.S. Supreme Court in consolidated patent litigations concerning the drug Copaxone®.
  • Wins in D.N.J. (after trial) and Federal Circuit in patent litigation concerning the drug Atelvia®.
  • Win in D. Del. (after trial) in patent litigation concerning the drug Quillivant®.
  • Win in D. Del. (motion for judgment under Rule 52(c) granted during trial) in patent litigation concerning the drug Uceris®.
  • Wins at PTAB in IPRs on patents on the drug Ravicti.
  • Win in D.N.J. (defeated TRO and PI motions) in patent litigation concerning the drug Abilify®. Achieved subsequent favorable settlement.
  • Wins in S.D. Ind. (after trial) and Federal Circuit in patent litigation concerning the drug Gemzar®.
  • Win in D. Mass. (after trial) in patent litigation concerning the drug Relafen®. Achieved favorable settlement while on appeal.
  • Wins in D. Del. (on summary judgment) and Federal Circuit in patent litigation concerning coronary stents.
  • Wins in S.D.N.Y. (on summary judgment) and Federal Circuit in patent litigation concerning pertussis vaccines.
  • Win in D.N.J. in a false advertising case concerning x-ray contrast agents.

Ms. Holland has also achieved numerous favorable settlements on behalf of clients.

Prior to joining Goodwin in 2014, Ms. Holland was a partner at Kenyon & Kenyon in New York City, where she chaired its Diversity Committee and was the first woman to serve on its Management Committee. She previously practiced at Paul Weiss, where she litigated a variety of cases, including patent infringement, securities, real estate and contract matters.


Ms. Holland is currently recognized as a leading lawyer by Chambers USA; is ranked in the Gold Band in the IAM 1000 – The World's Leading Patent Practitioners; has been named an "IP Star" by Managing Intellectual Property; and is a fellow of the Litigation Counsel of America. She is a past recipient of the Euromoney Women in Business Law Best in Life Sciences Award and is two-time winner of the LMG Life Sciences Hatch-Waxman Litigator of the Year Award. She has also been featured as a “Winning Litigator” in the National Law Journal and a “Trial Pro” in Law360.

In The News


Dans les Nouvelles




Lettres de Créance



J.D., 1988
Benjamin N. Cardozo School of Law
(magna cum laude)
B.S., Chemical Engineering, 1985
The Cooper Union



New York
U.S. Patent and Trademark Office (USPTO)


U.S. District Court for the Eastern District of New York
U.S. District Court for the Southern District of New York
U.S. Court of Appeals for the Federal Circuit
U.S. Supreme Court
Get In Touch
Entrer en contact
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

Nos clients comptent sur nous pour des services de conseil de classe mondiale, des conseils sur le travail transactionnel complexe et des litiges à enjeux élevés. Spécialisés dans les domaines de la finance, des sciences de la vie, du capital-investissement, de l'immobilier et de la technologie, nous utilisons une approche collaborative et interdisciplinaire pour résoudre les problèmes les plus complexes de nos clients. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique